Cascader Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 2

Cascader General Information

Description

Developer of medical artificial intelligence technology intended to support evidence-based clinical decision-making and disease detection through retinal imaging. The company's platform specializes in leveraging deep learning algorithms trained on retinal imaging to assist clinicians in diagnosing high-risk eye conditions, monitoring treatment outcomes, and identifying early signs of systemic diseases such as cardiovascular and neurodegenerative disorders.

Contact Information

Website
www.cascader.ai
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3rd Floor 86-90 Paul Street
  • London EC2A 4NE
  • England, United Kingdom
Primary Industry
Decision/Risk Analysis
Other Industries
Diagnostic Equipment
Vertical(s)
Artificial Intelligence & Machine Learning, HealthTech
Corporate Office
  • 3rd Floor 86-90 Paul Street
  • London EC2A 4NE
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cascader Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC Completed Generating Revenue
To view Cascader’s complete valuation and funding history, request access »

Cascader Patents

  • 6

    Total Documents Applications and Grants

  • Total Patents Families

  • 6

    Granted

  • Pending

  • Expiring in next 12 mo

Cascader Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10198832-B2 Generalizable medical image analysis using segmentation and classification neural networks Active 28-Jun-2017
US-10878601-B2 Generalizable medical image analysis using segmentation and classification neural networks Active 28-Jun-2017
US-11954902-B2 Generalizable medical image analysis using segmentation and classification neural networks Active 28-Jun-2017
US-20190005684-A1 Generalizable medical image analysis using segmentation and classification neural networks Active 28-Jun-2017
US-20190139270-A1 Generalizable medical image analysis using segmentation and classification neural networks Active 28-Jun-2017 G06V10/82
To view Cascader’s complete patent history, request access »

Cascader Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cascader Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Topcon Healthcare VC-Backed Company Minority
UCL Ventures University Minority
To view Cascader’s complete investors history, request access »

Ready to get started?

Request a free trial

Cascader FAQs

  • When was Cascader founded?

    Cascader was founded in 2025.

  • Where is Cascader headquartered?

    Cascader is headquartered in London, United Kingdom.

  • What is the size of Cascader?

    Cascader has 5 total employees.

  • What industry is Cascader in?

    Cascader’s primary industry is Decision/Risk Analysis.

  • Is Cascader a private or public company?

    Cascader is a Private company.

  • What is Cascader’s current revenue?

    The current revenue for Cascader is .

  • Who are Cascader’s investors?

    Topcon Healthcare and UCL Ventures have invested in Cascader.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process